JP2532495B2 - Skin cosmetics - Google Patents

Skin cosmetics

Info

Publication number
JP2532495B2
JP2532495B2 JP62196928A JP19692887A JP2532495B2 JP 2532495 B2 JP2532495 B2 JP 2532495B2 JP 62196928 A JP62196928 A JP 62196928A JP 19692887 A JP19692887 A JP 19692887A JP 2532495 B2 JP2532495 B2 JP 2532495B2
Authority
JP
Japan
Prior art keywords
skin
estrogen
vitamin
glycosaminoglycan
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62196928A
Other languages
Japanese (ja)
Other versions
JPS6440412A (en
Inventor
博 上坂
政雄 釈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Priority to JP62196928A priority Critical patent/JP2532495B2/en
Publication of JPS6440412A publication Critical patent/JPS6440412A/en
Application granted granted Critical
Publication of JP2532495B2 publication Critical patent/JP2532495B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、皮膚の柔軟性、弾力性および表面状態を著
しく改善する化粧料に関する。さらに詳しく言えば、本
発明は、皮膚に潤いを与え、皮膚の生理機能を向上させ
て皮膚の柔軟性、弾力性および表面状態を著しく改善す
る皮膚化粧料に関するものである。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a cosmetic composition which markedly improves the flexibility, elasticity and surface condition of the skin. More specifically, the present invention relates to a skin cosmetic that moisturizes the skin and improves the physiological function of the skin to remarkably improve the flexibility, elasticity and surface condition of the skin.

〔従来の技術〕[Conventional technology]

皮膚は老化にともない、皮膚の保水機能が低下し、乾
燥し、潤いのないあれ肌となる。その原因として、皮膚
中のグリコサミノグリカンが加齢とともに減少するため
といわれている。
As the skin ages, the water retention function of the skin deteriorates and the skin becomes dry and moist. It is said that the cause is that glycosaminoglycan in the skin decreases with age.

これまでの化粧料は、皮膚に不足しているグリコサミ
ノグリカンを配合し、中でも強い保水性を持つヒアルロ
ン酸により皮膚をなめらかにし皮膚に適度な潤いを与え
ようとしてきた(特公昭33-500号、特公昭55-160712
号)。しかし、この外部からの保湿成分の補足では効果
に限界があるので、皮膚内部に働きかけ皮膚の機能を高
めて保湿性を高めるためにヒアルロン酸合成に関与する
生理活性物質を配合していた。例えば真皮のヒアルロン
酸生合成能を高めるエストロゲンを配合した化粧料や、
エストロゲンとグリコサミノグリカンとを組合せて相乗
効果を求めた化粧料(特開昭59-25311号)、また表皮の
ヒアルロン酸生合成能を高めるビタミンAを配合した
り、あるいはグリコサミノグリカンとビタミンAを組合
わせ配合した化粧料(特開昭60-252405号)等の技術が
開示されていた。
Until now, cosmetics have blended glycosaminoglycan, which is lacking in the skin, and have tried to moisturize and moisturize the skin with hyaluronic acid, which has a strong water retention property (JP-B-33-500). Issue, Shokoku Sho 55-160712
issue). However, since supplementation of the moisturizing component from the outside has a limited effect, a physiologically active substance involved in hyaluronic acid synthesis has been blended in order to act on the inside of the skin to enhance the function of the skin and enhance the moisturizing property. For example, cosmetics containing estrogen that enhances hyaluronic acid biosynthesis in the dermis,
Cosmetics that seek a synergistic effect by combining estrogen and glycosaminoglycan (Japanese Patent Laid-Open No. 59-25311), blend with vitamin A that enhances hyaluronic acid biosynthesis in the epidermis, or combine glycosaminoglycan Techniques such as cosmetics containing a combination of vitamin A (JP-A-60-252405) have been disclosed.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

しかし外部から補充したグリコサミノグリカンは洗顔
や汗などにより簡単に洗い流されてしまうため、グリコ
サミノグリカンのみを配合した化粧料は長期に亘る効果
という点で不十分であった。またエストロゲンやビタミ
ンAは皮膚の内面から働きかけ長期の作用を期待できる
が、エストロゲンは真皮に対する効果が大部分で、エス
トロゲンとグリコサミノグリカンを配合した化粧料では
表皮の状態と密接に関係する皮膚のなめらかさ、皮膚表
面の適度な潤いに効果を与えることはほとんど期待でき
ないし、一方ビタミンAは表皮に対する効果が大部分
で、ビタミンAとグリコサミノグリカンを配合した化粧
料では皮膚の弾力性、皮膚の適度なハリを左右する真皮
への効果はほとんど無いと考えられた。その為、従来の
技術では皮膚組織全体の保水性を高める面で不足であ
り、皮膚の柔軟性、弾力性、保水性の年齢による低下に
対して十分な効果を示さなかった。
However, the glycosaminoglycan replenished from the outside is easily washed off by washing the face, sweating, etc., so that the cosmetic containing only glycosaminoglycan was insufficient in terms of long-term effect. Estrogen and Vitamin A work from the inside of the skin and can be expected to have a long-term effect, but estrogen has most of the effect on the dermis, and cosmetics containing estrogen and glycosaminoglycan are closely related to the condition of the epidermis. It can hardly be expected to have an effect on the smoothness and proper moisturization of the skin surface, while vitamin A has the most effect on the epidermis, and cosmetics containing vitamin A and glycosaminoglycan have elasticity on the skin. , It is considered that there is almost no effect on the dermis that influences the proper firmness of the skin. Therefore, the conventional techniques are insufficient in terms of enhancing the water retention of the entire skin tissue, and have not shown sufficient effects on the deterioration of skin flexibility, elasticity and water retention with age.

〔問題点を解決する手段〕[Means for solving problems]

そこで本発明者らは鋭意研究の結果、表皮のグリコサ
ミノグリカンの生合成能を高め、皮膚になめらかさ、適
度な潤いを与えるビタミンAおよび真皮のグリコサミノ
グリカンの生合成能を高め、肌に弾力性、適度なハリを
与えるエストロゲンを一定量配合した化粧料が、ビタミ
ンA、エストロゲンあるいはグリコサミノグリカン単独
配合や、エストロゲンとグリコサミノグリカンとの組合
わせ、そしてビタミンAとグリコサミノグリカンの組合
わせよりも皮膚の柔軟性、弾性および表面状態を改善す
る効果が大きいことを見い出し本発明を完成するに至っ
た。
Therefore, as a result of diligent research, the present inventors have increased the biosynthesis ability of glycosaminoglycans in the epidermis, and have increased the biosynthesis ability of vitamin A and dermis glycosaminoglycans that provide smoothness and appropriate moisturization to the skin Cosmetics containing a certain amount of estrogen that gives elasticity and moderate elasticity to the skin can be formulated with vitamin A, estrogen or glycosaminoglycan alone, a combination of estrogen and glycosaminoglycan, and vitamin A and glycosaminoglycan. The inventors have found that the effect of improving the flexibility, elasticity and surface condition of the skin is greater than the combination of noglycans, and have completed the present invention.

すなわち本発明は、ビタミンA 0.001〜0.01重量%及
びエストロゲン 0.001〜0.01重量%を配合することを特
徴とする皮膚化粧料に関する。
That is, the present invention relates to a skin cosmetic characterized by containing 0.001 to 0.01% by weight of vitamin A and 0.001 to 0.01% by weight of estrogen.

以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.

本発明で用いるエストロゲンは、別名「卵胞ホルモ
ン」と称され、例えばエチニルエストラジオール、17β
−エストラジオール、エストロン、エストリオール、ジ
エチルスチルベストロール、ヘキセストロール等であ
り、これらのうちから1種又は2種以上を任意に選び使
用する。配合量は0.001重量%以上、0.01重量%以下と
する(0.001%未満では効果を発揮しないし、0.01%を
越すと副作用の危険性がある。)。
The estrogen used in the present invention is also known as "estrogen", and includes, for example, ethinyl estradiol, 17β.
-Estradiol, estrone, estriol, diethylstilbestrol, hexestrol and the like, and one or more of these are arbitrarily selected and used. The blending amount is 0.001% by weight or more and 0.01% by weight or less (less than 0.001% does not exhibit the effect, and if it exceeds 0.01%, there is a risk of side effects).

本発明で用いるビタミンAは、例えばレチノール、レ
チナール、デヒドロレチノール、デヒドロレチナールお
よびこれらのエステル類あるいはカロチン、リコビン、
ゼアキサンチン、クリプトキサンチン、エキネノン等の
プロビタミン類であり、これらのうちから1種又は2種
以上を任意に選び使用する。配合量は0.001重量%以
上、0.01重量%以下とする(0.001%未満では効果を発
揮しないし、0.01%を越すと副作用の危険性があ
る。)。
Vitamin A used in the present invention is, for example, retinol, retinal, dehydroretinol, dehydroretinal and their esters or carotene, lycobin,
These are provitamins such as zeaxanthin, cryptoxanthin, and echinenone, and one or more of these are arbitrarily selected and used. The blending amount is 0.001% by weight or more and 0.01% by weight or less (less than 0.001% does not exhibit the effect, and if it exceeds 0.01%, there is a risk of side effects).

またエストロゲンとビタミンAの比率は1:1/2〜2の
範囲で皮膚に対して有効であり、この比率の範囲で使用
することが好ましい。
The ratio of estrogen to vitamin A is effective in the skin in the range of 1: 1/2 to 2, and it is preferable to use it in the range of this ratio.

本発明の皮膚化粧料は前記の必須成分以外に、必要に
応じて本発明の効果を損わない範囲で化粧品、医薬品等
に一般に用いられる各種成分、すなわち水性成分、粉末
成分、油分、界面活性剤、保湿剤、増粘剤、酸化防止
剤、香料、色材、紫外線吸収剤、ビタミン類、薬剤等を
配合できる。また、前項で示したビタミンAとエストロ
ゲンの構成比によって異なるが、状況に応じてビタミン
Aとエストロゲンの効果を補足する意味でグリコサミノ
グリカンを該化粧料に対して0.01%以上10%以下の範囲
で配合することもできる(0.01未満では効果を補足する
のに十分でなく、10%を越すと化粧品剤型上好ましくな
い。)。
The skin cosmetics of the present invention include, in addition to the above-mentioned essential components, various components generally used in cosmetics, pharmaceuticals, etc., if necessary, within a range that does not impair the effects of the present invention, that is, an aqueous component, a powder component, an oil component, and a surfactant Agents, moisturizers, thickeners, antioxidants, fragrances, coloring materials, ultraviolet absorbers, vitamins, drugs and the like can be added. Also, depending on the composition ratio of vitamin A and estrogen shown in the preceding paragraph, glycosaminoglycan is added to the cosmetic in an amount of 0.01% or more and 10% or less in order to complement the effects of vitamin A and estrogen depending on the situation. It can be blended in a range (less than 0.01 is not sufficient to supplement the effect, and if it exceeds 10%, it is not preferable in terms of cosmetic dosage form).

尚、ここで用いるグリコサミノグリカンは、例えばヒ
アルロン酸、コンドロイチン硫酸A、コンドロイチン硫
酸B、コンドロイチン硫酸C、ヘプラン等および(また
は)その塩類である。グリコサミノグリカンの塩を形成
する塩基としては水酸化リチウム、水酸化カリウム、水
酸化ナトリウム等の無機塩、トリエタノールアミン等の
有機塩基およびリジン、アルギニン、β−アラニン等の
塩基性アミノ酸等を例示できる。
The glycosaminoglycan used here is, for example, hyaluronic acid, chondroitin sulfate A, chondroitin sulfate B, chondroitin sulfate C, heplan, and / or salts thereof. As the base forming the salt of glycosaminoglycan, lithium hydroxide, potassium hydroxide, inorganic salts such as sodium hydroxide, organic bases such as triethanolamine and lysine, arginine, basic amino acids such as β-alanine It can be illustrated.

以下実施例により本発明および本発明の効果について
記述する。
The present invention and the effects of the present invention will be described below with reference to examples.

(製法) 成分A(油相部)および成分B(水相部)をそれぞれ
70℃に加熱し完全溶解したのち、油相部を水相部中に混
合し乳化し、熱交換器にて30℃まで冷却し、作成した。
(Manufacturing method) Component A (oil phase part) and component B (water phase part) respectively
After heating to 70 ° C. to completely dissolve, the oil phase part was mixed with the water phase part to emulsify, and cooled to 30 ° C. in a heat exchanger to prepare.

(使用テスト) 本発明の皮膚化粧料の作用効果を、使用テストにより
試験した。使用テストは70名の女性パネラーを各群10名
づつの7群に分け、第1群には実施例1のクリームを、
第2群には比較例1のクリームを、第3群には比較例2
のクリームを、第4群には比較例1のクリームを、第5
群には比較例4のクリームを第6群には比較例5のクリ
ームを、第7群には比較例6のクリームを、それぞれ1
日1回20日間に亘って塗布し、20日後の効果を「肌の弾
力性および適度なハリ」「肌のしっとり感」の2項目に
つき、その有効性を判定した。結果は表−1に示すとお
りである。
(Use test) The action effect of the skin cosmetic of the present invention was tested by a use test. In the use test, 70 female panelists were divided into 7 groups of 10 persons in each group, and the cream of Example 1 was used in the first group.
The cream of Comparative Example 1 was used for the second group, and Comparative Example 2 was used for the third group.
The cream of Comparative Example 1 to the 4th group and the 5th
The cream of Comparative Example 4 was applied to the group, the cream of Comparative Example 5 was applied to the sixth group, and the cream of Comparative Example 6 was applied to the seventh group.
It was applied once a day for 20 days, and the effect after 20 days was evaluated for the two items of "skin elasticity and proper firmness" and "skin moist feeling". The results are as shown in Table 1.

(製法) 70℃に保った成分B(水相)に成分A(油相)を70℃
にて加え、ホモミキサーで均一に乳化後冷却する。
(Manufacturing method) Component A (oil phase) is added to component B (water phase) kept at 70 ° C.
And homogenize with a homomixer and then cool.

(使用テスト) 肌あれ症状を自己申告パネラーを70名を7群に分け、
第1群には実施例2の化粧水を、第2群には比較例7の
化粧水を、第3群には比較例8の化粧水を、第4群には
比較例9の化粧水を、第5群には比較例10の化粧水を、
第6群には比較例11の化粧水を、第7群には比較例12の
化粧水をそれぞれ1ヶ月に亘って塗布し、肌あれ改善が
なされたかどうかにつき、その有効性を判定した。結果
は表−2に示すとおり。
(Usage test) 70 people with 70 self-reported panelists for skin symptoms,
The first group contains the lotion of Example 2, the second group contains the lotion of Comparative Example 7, the third group contains the lotion of Comparative Example 8, and the fourth group contains the lotion of Comparative Example 9. To the fifth group, the lotion of Comparative Example 10 was added,
The lotion of Comparative Example 11 was applied to the 6th group, and the lotion of Comparative Example 12 was applied to the 7th group for 1 month, and the effectiveness thereof was determined by whether or not skin roughness was improved. The results are shown in Table-2.

これらの結果から明らかなようにビタミンAをエスト
ロゲンを配合した皮膚化粧料は、ビタミンAまたはエス
トロゲン単独配合、あるいはビタミンAとグリコサミノ
グリカンの組合わせ配合、エストロゲンとグリコサミノ
グリカンの組合わせ配合時よりも肌に「弾力性」「しっ
とり感」が著しく増強され「肌あれが改善された」とい
う効果が確認された。
As is clear from these results, the skin cosmetics containing vitamin A and estrogen are vitamin A or estrogen alone, a combination of vitamin A and glycosaminoglycan, a combination of estrogen and glycosaminoglycan. It was confirmed that the "elasticity" and "moisturizing feeling" were remarkably enhanced on the skin rather than the time, and "the rough skin was improved".

更に実施例を以下に記載する。 Further examples are described below.

実施例3 ファンデーション 疎水性化微粒子酸化チタン 7.0 イソステアリン酸トリグリセライド 2.0 2−オクチルドデシルオレート 8.0 流動パラフィン 3.0 セチルアルコール 5.0 キァンデリラワックス 2.0 POE(25)モノステアレート 2.0 ソルビタンモノステアレート 1.0 黄酸化鉄 1.3 弁柄 0.8 ポリエチレングリコール 4.0 メチルパラベン 0.2 ヒアルロン酸ナトリウム 0.5 香料 0.2 ジエチルスチルベストロール 0.002 レチナール 0.002 精製水 残余 実施例4 パック ポリビニルアルコール 20.0 エタノール 20.0 ヒアルロン酸ナトリウム 0.2 グリセリン 5.0 香料 0.3 エチニルエストラジオール 0.004 レチナール 0.004 精製水 残余 実施例5 オイル スクワラン 47.0 ヒマシ油 47.0 ジエチルスチルベストロール 0.005 レチナール 0.005 精製水 残余Example 3 Foundation Hydrophobized Fine Particle Titanium Oxide 7.0 Isostearic Acid Triglyceride 2.0 2-Octyldodecyl Olate 8.0 Liquid Paraffin 3.0 Cetyl Alcohol 5.0 Candelilla Wax 2.0 POE (25) Monostearate 2.0 Sorbitan Monostearate 1.0 Yellow Iron Oxide 1.3 Valve Pattern 0.8 Polyethylene glycol 4.0 Methylparaben 0.2 Sodium hyaluronate 0.5 Fragrance 0.2 Diethylstilbestrol 0.002 Retinal 0.002 Purified water Residual Example 4 Packed polyvinyl alcohol 20.0 Ethanol 20.0 Hyaluronate 0.2 Glycerin 5.0 Fragrance 0.3 Ethinyl estradiol 0.004 Retinal 0.004 Purified water Residual example 5 Oil Squalane 47.0 Castor oil 47.0 Diethylstilbestrol 0.005 Retinal 0.005 Purified water Residual

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】ビタミンA 0.001〜0.01重量%及びエスト
ロゲン 0.001〜0.01重量%を配合することを特徴とする
皮膚化粧料
1. A skin cosmetic composition comprising 0.001 to 0.01% by weight of vitamin A and 0.001 to 0.01% by weight of estrogen.
JP62196928A 1987-08-06 1987-08-06 Skin cosmetics Expired - Lifetime JP2532495B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62196928A JP2532495B2 (en) 1987-08-06 1987-08-06 Skin cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62196928A JP2532495B2 (en) 1987-08-06 1987-08-06 Skin cosmetics

Publications (2)

Publication Number Publication Date
JPS6440412A JPS6440412A (en) 1989-02-10
JP2532495B2 true JP2532495B2 (en) 1996-09-11

Family

ID=16365996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62196928A Expired - Lifetime JP2532495B2 (en) 1987-08-06 1987-08-06 Skin cosmetics

Country Status (1)

Country Link
JP (1) JP2532495B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2931708B2 (en) * 1991-07-18 1999-08-09 ポーラ化成工業株式会社 Hair restoration
US5565207A (en) * 1990-09-19 1996-10-15 Pola Kasei Kogyo Kabushiki Kaisha Scalp moisturizer and external skin preparation
JPH0632722A (en) * 1992-07-13 1994-02-08 Shiseido Co Ltd External preparation for skin
MXPA02004933A (en) * 1999-11-16 2004-08-12 Unilever Nv Cosmetic compositions containing chick pea extract and retinoids.
FR2865651B1 (en) * 2004-01-29 2007-09-28 Fabre Pierre Dermo Cosmetique TOPICAL COMPOSITIONS COMPRISING SODIUM HYALURONATE FRAGMENTS AND RETINOID USEFUL IN COSMETIC AND MEDICAL DERMATOLOGY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925311A (en) * 1982-07-29 1984-02-09 Shiseido Co Ltd Cosmetic
JPS61251606A (en) * 1985-04-30 1986-11-08 Shiseido Co Ltd Cosmetic
JPS62411A (en) * 1985-06-25 1987-01-06 Shiseido Co Ltd Cosmetic

Also Published As

Publication number Publication date
JPS6440412A (en) 1989-02-10

Similar Documents

Publication Publication Date Title
JP5093998B2 (en) Pigmentation preventing or improving agent
JP4670366B2 (en) Skin cosmetics
US5153230A (en) Topical skin cream composition
JP5766258B2 (en) Pigmentation preventing or improving agent
JPS59134706A (en) Cosmetic
JP3432848B2 (en) Hair restorer
JPH0380123B2 (en)
DE10033717A1 (en) Cosmetic and dermatological preparation for removing sebum
JP2002193755A (en) Antidandruff and anti-itching hair cosmetic and hair- shampooing cosmetic
JP3513872B2 (en) External preparation for skin
JP2532495B2 (en) Skin cosmetics
JPH0393707A (en) Oil-in-water type emulsion cosmetic
JPH09183718A (en) Composition suitable for external application
JPH09221410A (en) Aging preventing skin ointment
JP2006321758A (en) Cosmetic
JPH11139951A (en) Cosmetic
JPH0420883B2 (en)
JP4828077B2 (en) Topical skin preparation
JPS60116618A (en) Cosmetic
JP2010189368A (en) Liquid external preparation for skin
JP3104938B2 (en) Cosmetics
JP2000344697A (en) Long-chain branched alcohol and cosmetic and external preparation produced by using the alcohol
JP2002275027A (en) Cosmetic and cosmetic impregnated in nonwoven fabric
JP3556479B2 (en) Skin pre-treatment agent
JPH10279427A (en) Moisture-retaining cosmetic material composition